<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
   <META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=iso-8859-1">
   <META NAME="GENERATOR" CONTENT="Mozilla/4.07 [en] (X11; I; HP-UX B.10.20 9000/712) [Netscape]">
   <TITLE>Guidlines and Procedures for Establishing and Maintaining EPD Cross-References</TITLE>
</HEAD>
<BODY>

<H1>
Guidelines and Procedures for Establishing and Maintaining EPD Cross-References</H1>

<H3>
Purpose of this document:</H3>
The purpose of this document is to make clear for each type of Cross-references:
<OL>
<LI>
The type-specific format of the cross-reference.</LI>

<LI>
The biological meaning of the cross-reference.</LI>

<LI>
The conditions and rules for establishing and maintaining of a cross-reference.</LI>

<LI>
The strategies for identifying new targets.</LI>

<LI>
The procedures for storage, update, verification of existing cross-references.</LI>
</ol>
<HR>
<H3>
<TT>DR EPD</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; EPD; "AC"; "ID"; "definition"; "position; direction"</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"AC"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>EPD accession number.</TD>
</TR>

<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>EPD identification.&nbsp;</TD>
</TR>

<TR VALIGN=TOP>
<TD>"definition"&nbsp;</TD>

<TD>keyword</TD>

<TD>alternative promoter</TD>
</TR>

<TR VALIGN=TOP>
<TD>"position; direction"&nbsp;</TD>

<TD>seq_pos&nbsp;</TD>

<TD>Position and direction relative to the transcription initiation site.</TD>
</TR>
</TABLE>
</UL>
2. Biological meaning:
<UL>Multiple initiation sites preceding the same structural gene appear
as alternative promoters if they are clearly separated from each other
or differentially regulated.</UL>

<P><BR>3. Conditions and rules:
<UL>The minimum distance required between two alternative initiation sites
is 20 bp.</UL>

<P><BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<P>
<HR>
<H3>
<TT>DR EMBL</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; EMBL; "SV"; "ID"; "position".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"SV"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>EMBL sequence version.</TD>
</TR>

<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>EMBL identification.&nbsp;</TD>
</TR>

<TR VALIGN=TOP>
<TD>"position"&nbsp;</TD>

<TD>seq_pos&nbsp;</TD>

<TD>Position of the EPD transcription initiation site.</TD>
</TR>
</TABLE>

<P>Note: seq_pos is a positional sequence object represented according
to the <A HREF="#Milano">Milano</A> convention.</UL>
2. Biological meaning:
<BR>3. Conditions and rules:
<BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<P>
<HR>
<H3>
<TT>DR SWISS-PROT</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; SWISS-PROT; "AC"; "ID".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"AC"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>SWISS-PROT accession number.</TD>
</TR>

<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>SWISS-PROT identification.&nbsp;</TD>
</TR>
</TABLE>
</UL>
2. Biological meaning:
<BR>3. Conditions and rules:
<BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<H3>

<HR></H3>

<H3>
<TT>DR TRANSFAC</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; TRANSFAC; "AC"; "ID"; "position"; "type".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"AC"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>TransFac accession number.</TD>
</TR>

<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>Transfac identification.&nbsp;</TD>
</TR>

<TR VALIGN=TOP>
<TD>"position"&nbsp;</TD>

<TD>seq_pos&nbsp;</TD>

<TD>Position of site relative to the EPD initiation site.</TD>
</TR>

<TR VALIGN=TOP>
<TD>"type"&nbsp;</TD>

<TD>keyword&nbsp;</TD>

<TD>Type of initiation sites.&nbsp;</TD>
</TR>
</TABLE>

<P>Notes:
<BR>seq_pos is a positional sequence object represented according to
<BR>the <A HREF="#Milano">Milano</A> convention.
<P>Valid keywords for "type" are: "by position", "by function".</UL>
2. Biological meaning:
<UL>There are two types of cross-references, distuinguished by the keywords
"by position" and "by function". "By position" means that the site described
in TRANSFAC falls withing the range [-500,+100] of the initiation sites.
"By function" means that the site has been reported to regulate transcription
from the initiation site described by the EPD entry. "By position" cross-references
are typically generated by an automatic procedure. "By function" cross-references
are established by literature scanning. "By position" generally does not
exclude "by function"; it simply means that a functional relationship has
not (yet) come to the attention of the EPD curator.</UL>

<P><BR>3. Conditions and rules:
<UL>Rule 1: Only site entries describing inidividual sites (as opposed
to consensus sequences) which contain at least one SQ line, and share at
least one EMBL cross-reference with a corresponding EPD entry can be cross-referenced
cross-referenced.
<P>Rule 2: For a given pair of a TRANSFAC and an EPD entry, there can be
at most one cross-reference for each SQ line in the TRANSFAC entry. A cross-reference
can only be created for an SQ line, if the sequence matches a range of
an EMBL sequence indicated</UL>

<P><BR>4. Target identification:
<UL>Difficult TRANSFAC entries:
<P>TRANSFAC entries containing multiple SQ lines with identical sequences
may cause promblems to automatic procedures for establishing "by position"
cross-references. There is a program for identification of such entries
which can be used in the following way:
<PRE>&nbsp;&nbsp; g77 -fno-automatic /home/epd/src/find_difficult_sites.f&nbsp;
&nbsp;&nbsp; ./a.out &lt; /db/transfac/site.dat</PRE>
In release 35, the following entries were found:
<PRE>&nbsp;&nbsp; R00052(not in 61)
&nbsp;&nbsp; R00281&nbsp;&nbsp;
&nbsp;&nbsp; R00470&nbsp;&nbsp;
&nbsp;&nbsp; R00603&nbsp;&nbsp;
&nbsp;&nbsp; R00825(not in 61)&nbsp;
&nbsp;&nbsp; R00826 "
&nbsp;&nbsp; R02711&nbsp;&nbsp;
&nbsp;&nbsp; R02728 "&nbsp;
&nbsp;&nbsp; R03466 "
&nbsp;&nbsp; R03715&nbsp;&nbsp;
&nbsp;&nbsp; R03735 "</PRE>
These entries may have to be processed manually.
<P>Verification of positions:
<P>Examples:
<TABLE BORDER >
<TR>
<TD>1. EPD on + strand, TRANSFAC site on + strand:&nbsp;
<PRE>EPD:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | ID&nbsp;&nbsp; AD2_DNBI&nbsp;&nbsp;&nbsp;&nbsp; standard; single; VRT.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | AC&nbsp;&nbsp; EP07159;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | DE&nbsp;&nbsp; Major late promoter
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | OS&nbsp;&nbsp; Human adenovirus type 2
e1,e2 | DR&nbsp;&nbsp; EMBL; J01917; HACG; g209811; [-6038, 29899].
p1,p2 | DR&nbsp;&nbsp; TRANSFAC; R03156; AD$MLP_39; [-31,-24]; automatic.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SE&nbsp;&nbsp; gtgttcctgaaggggggctataaaagggggtgggggcgcgttcgtcctcACTCTCTTCCG

TRANSFAC:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | AC&nbsp;&nbsp; R03156
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | ID&nbsp;&nbsp; AD$MLP_39
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | DE&nbsp;&nbsp; MLP (major late promoter); G000010.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | SQ&nbsp;&nbsp; TATAAAA.
t1,t2 | DR&nbsp;&nbsp; EMBL: J01917; HACG(6008:6014).</PRE>
Conversion arithmetics:
<PRE>&nbsp;&nbsp; p1 = e1 + t1 - 1&nbsp;&nbsp;&nbsp;&nbsp; p2 = e1 + t2
&nbsp;&nbsp; t1 = p1 - e1 + 1&nbsp;&nbsp;&nbsp;&nbsp; t2 = p2 - e1</PRE>
</TD>
</TR>
</TABLE>
</UL>

<P><BR>5. Storage, maintenance and verification:
<BR>

<HR>
<H3>
<TT>DR FLYBASE</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; FLYBASE; "ID"; "symbol".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>FlyBase identification</TD>
</TR>

<TR VALIGN=TOP>
<TD>"symbol"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>FlyBase symbol.&nbsp;</TD>
</TR>
</TABLE>
</UL>
2. Biological meaning:
<BR>3. Conditions and rules:
<BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<BR>
<HR>
<H3>
<TT>DR MIM</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; FLYBASE; "ID"; "symbol".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"ID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>FlyBase identification</TD>
</TR>

<TR VALIGN=TOP>
<TD>"symbol"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>FlyBase symbol.&nbsp;</TD>
</TR>
</TABLE>
</UL>
2. Biological meaning:
<BR>3. Conditions and rules:
<BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<BR>
<HR>
<H3>
<TT>DR MGD</TT></H3>
1. Format:
<UL>
<PRE>DR&nbsp;&nbsp; MGD; "MGI:ACID"; "symbol".</PRE>

<TABLE BORDER >
<TR VALIGN=TOP>
<TD>"ACID"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>MGD accession identification</TD>
</TR>

<TR VALIGN=TOP>
<TD>"symbol"&nbsp;</TD>

<TD>string&nbsp;</TD>

<TD>MGD symbol.&nbsp;</TD>
</TR>
</TABLE>
</UL>

<P><BR>2. Biological meaning:
<BR>3. Conditions and rules:
<BR>4. Target identification:
<BR>5. Storage, maintenance and verification:
<H1>
APPENDICES</H1>

<H3>
A1 Representation of Positional Sequence Objects Convention:</H3>

<H3>
<A NAME="Milano"></A>1. The Milano convention</H3>
The Milano convention for defining the position of SEQUENCES relative to
a transcription inititation SITE (or another physiological sites wich logically
falls between adjacent bases) is ilustrated by the following example.
<UL>EPD EMBL and TRANSFAC cross-references:
<TABLE BORDER >
<TR>
<TD>
<PRE>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a C C C G C C t g c a c c c g a t t c a t g t g a g a a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;----------->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TRANSFAC entry R99999/ET$SITE_1&nbsp;&nbsp;&nbsp;&nbsp; +---> EPD entry EP99999&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; &lt;------------------------------------------------------->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; EMBL entry ZZ999999.1/HS28BP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;



<HR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; EMBL; ZZ999999.1; HS28BP; [-19, 9].&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; TRANSFAC; R99999; ET$SITE_1; [-18,-12], by position.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</PRE>
</TD>
</TR>
</TABLE>
</UL>
TRANSFAC applies the EMBL feature table numbering system for indicating
a SITE or SUBSEQUENCE within a SEQUENCE. (Note that this problem is slightly
different from the problem of indicating the position of a SEQUENCE relative
to a SITE.) The FP lines of EPD follow the EMBL convention by referring
to the first base of the transcript as the transcription initiation site.
<UL>TRANSFAC-EMBL cross-references and EPD FP lines:
<TABLE BORDER >
<TR>
<TD>
<PRE>&nbsp;&nbsp;&nbsp;&nbsp; 1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; a C C C G C C t g c a c c c g a t t c A T G T G A G A A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;--------->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TRANSFAC entry R99999/ET$SITE_1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EPD entry EP99999&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; &lt;----------------------------------------------------->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; EMBL entry ZZ999999.1/HS28BP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;



<HR>
&nbsp;&nbsp;&nbsp;&nbsp; AC&nbsp;&nbsp; R99999;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; ID&nbsp;&nbsp; ET$SITE_1;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; EMBL: ZZ999999; HS28BP(2:7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp; FP&nbsp;&nbsp; ET strange promoter :-S&nbsp; ETL:R99999.1&nbsp;&nbsp; 1+&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20; 99999.&nbsp;&nbsp;&nbsp;

</PRE>
</TD>
</TR>
</TABLE>
</UL>

<H3>
2. Format for sequence object positions</H3>

<UL>
<PRE>["begin","end"]</PRE>
where "begin" and "end" are integers reflecting the start and end position
of the biological sequence object, respectively.</UL>

</BODY>
</HTML>
